Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 25, 2022

SELL
$92.98 - $124.15 $2.24 Million - $2.99 Million
-24,060 Closed
0 $0
Q3 2021

Nov 03, 2021

BUY
$77.49 - $109.17 $118,637 - $167,139
1,531 Added 6.8%
24,060 $2.46 Million
Q2 2021

Jul 28, 2021

BUY
$86.59 - $107.47 $94,989 - $117,894
1,097 Added 5.12%
22,529 $2.15 Million
Q1 2021

May 05, 2021

BUY
$66.32 - $90.93 $142,455 - $195,317
2,148 Added 11.14%
21,432 $1.75 Million
Q4 2020

Feb 09, 2021

BUY
$46.7 - $75.22 $47,167 - $75,972
1,010 Added 5.53%
19,284 $1.31 Million
Q3 2020

Oct 20, 2020

BUY
$42.77 - $56.69 $80,664 - $106,917
1,886 Added 11.51%
18,274 $845,000
Q2 2020

Jul 20, 2020

BUY
$26.54 - $44.24 $12,128 - $20,217
457 Added 2.87%
16,388 $725,000
Q1 2020

May 12, 2020

BUY
$22.69 - $44.14 $361,474 - $703,194
15,931 New
15,931 $486,000

Others Institutions Holding AZTA

About Azenta, Inc.


  • Ticker AZTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 75,020,400
  • Market Cap $3.75B
  • Description
  • Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...
More about AZTA
Track This Portfolio

Track Stanley Laman Group, Ltd. Portfolio

Follow Stanley Laman Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stanley Laman Group, Ltd. with notifications on news.